Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.93% |
| 2 | Technology | 4.66% |
| 3 | Healthcare | 4.45% |
| 4 | Industrials | 4.14% |
| 5 | Consumer Discretionary | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
PUT
Federal Realty Investment Trust
FRT
$10.3B
| $2.35M | ﹤0.01% |
18,600
-1,900
| -9% | -$241K |
|
3977
PUT
Editas Medicine
EDIT
$433M
| $2.35M | ﹤0.01% |
73,900
+36,500
| +98% | +$1.18M |
|
3978
Franklin Emerging Market Core Dividend Tilt Index ETF
DIEM
$84.3M
| $2.35M | ﹤0.01% |
76,858
+12,488
| +19% | +$378K |
|
3979
ScottsMiracle-Gro
SMG
$3.55B
| $2.35M | ﹤0.01% |
29,790
+26,709
| +867% | +$2.1M |
|
|
CONN
3980
CALL
DELISTED
Conn's Inc.
CONN
| $2.34M | ﹤0.01% |
66,300
+7,100
| +12% | +$254K |
|
|
SGEN
3981
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.34M | ﹤0.01% |
30,400
+20,400
| +204% | +$1.5M |
|
|
BPMC
3982
CALL
DELISTED
Blueprint Medicines
BPMC
| $2.34M | ﹤0.01% |
30,000
+9,400
| +46% | +$653K |
|
3983
Monro
MNRO
$359M
| $2.34M | ﹤0.01% |
33,635
-22,461
| -40% | -$1.54M |
|
3984
HF Sinclair
DINO
$16.7B
| $2.34M | ﹤0.01% |
33,429
-395,839
| -92% | -$27.9M |
|
3985
CALL
Lennox International
LII
$14.6B
| $2.34M | ﹤0.01% |
10,700
+8,500
| +386% | +$1.85M |
|
3986
CALL
Oshkosh
OSK
$9.44B
| $2.34M | ﹤0.01% |
32,800
+14,700
| +81% | +$1.06M |
|
3987
TriMas Corp
TRS
$1.4B
| $2.34M | ﹤0.01% |
76,866
-9,637
| -11% | -$292K |
|
|
BEAT
3988
DELISTED
BioTelemetry, Inc.
BEAT
| $2.34M | ﹤0.01% |
36,256
+31,308
| +633% | +$1.75M |
|
|
EBIX
3989
DELISTED
Ebix Inc
EBIX
| $2.34M | ﹤0.01% |
29,528
-8,325
| -22% | -$663K |
|
3990
CALL
Shutterstock
SSTK
$210M
| $2.34M | ﹤0.01% |
42,800
-4,500
| -10% | -$232K |
|
3991
Vanguard Short-Term Treasury ETF
VGSH
$30.2B
| $2.33M | ﹤0.01% |
+39,078
| New | +$2.34M |
|
3992
SolarEdge
SEDG
$1.99B
| $2.33M | ﹤0.01% |
61,995
+46,726
| +306% | +$2.25M |
|
|
CTB
3993
CALL
DELISTED
Cooper Tire & Rubber Co.
CTB
| $2.33M | ﹤0.01% |
82,400
+53,900
| +189% | +$1.54M |
|
3994
PUT
Global Payments
GPN
$24.6B
| $2.33M | ﹤0.01% |
18,300
-2,400
| -12% | -$289K |
|
3995
PUT
ResMed
RMD
$32.4B
| $2.33M | ﹤0.01% |
20,200
-2,000
| -9% | -$219K |
|
3996
iShares US Medical Devices ETF
IHI
$3.46B
| $2.33M | ﹤0.01% |
+61,434
| New | +$2.18M |
|
3997
CALL
Expeditors International
EXPD
$24.2B
| $2.32M | ﹤0.01% |
31,600
+8,700
| +38% | +$643K |
|
|
GOOS
3998
Canada Goose Holdings
GOOS
$854M
| $2.32M | ﹤0.01% |
36,031
-152,243
| -81% | -$8.89M |
|
3999
Liberty Media Series A
FWONA
$23.9B
| $2.32M | ﹤0.01% |
68,187
+27,856
| +69% | +$924K |
|
4000
CALL
Icon
ICLR
$12.6B
| $2.32M | ﹤0.01% |
15,100
-13,700
| -48% | -$1.96M |
|
Similar funds
Ken Griffin's Q3 2018 Portfolio in Review
As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Ken Griffin opened 1,427 new positions and closed 1,043 in Q3 2018.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.